CSTF.US CuraScientific Corp.
- Market cap
- USD 377K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is CSTF.US undervalued?
Graham numberThe Graham number of CuraScientific Corp. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CuraScientific Corp. fundamental analysis
No fundamental analysis for CuraScientific Corp. yet.
CuraScientific Corp. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CuraScientific Corp.
CuraScientific Corp. engages in the manufacturing, distribution, and sale of cannabis products under the JW Brands and Chad Enterprises brand names. It offers cannabidiol, kava, and kratom. The company was formerly known as Boon Industries, Inc. and changed its name to CuraScientific Corp. in April 2023. CuraScientific Corp. was incorporated in 2020 and is based in Coachella, California.
Full company profileCuraScientific Corp. financial statements
CuraScientific Corp. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 239K | 85.7K | 81.5K | 60.2K | 86.3K | 34.4K | 1.05M |
| Gross Profit | 29.3K | 56.5K | 54.9K | 41.7K | 55.3K | -1.14M | 475K |
| Operating Income | 25.4K | 10.9K | 2.91K | -2.53M | -4.78M | -2.38M | -2.89M |
| EBITDA | 25.4K | 21.9K | 13.9K | -4.11M | -4.10M | -4.03M | - |
| Net Income | 25.4K | -796.00 | -10.7K | -4.86M | -5.87M | -5.27M | 33.7M |
| EPS | 42 | -1.30 | -17 | -82 | -19 | -1.11 | - |
| Balance Sheet | |||||||
| Total Assets | 52.7K | 120K | 389K | 2.73M | 2.24M | 1.55M | - |
| Total Liabilities | 27.4K | 116K | 399K | 199M | 71.6M | 71.1M | - |
| Shareholders' Equity | 25.4K | 4.04K | -9.52K | -197M | -69.4M | -69.5M | - |
| Cash & Short-term Investments | 1.03K | 4.04K | 2.44K | 7.19K | 23.4K | 130.00 | - |
| Total Debt | 27.4K | 116K | 399K | 439K | 1.06M | 2.64M | - |
| Cash Flow | |||||||
| Operating Cash Flow | -24.4K | 11.7K | 1.30K | -433K | -554K | -254K | -304K |
| Capital Expenditure | 0.00 | 0.00 | 5.61K | 5.61K | 5.61K | 14.9K | 148K |
| Free Cash Flow | -24.4K | 11.7K | 1.30K | -433K | -559K | -269K | -452K |
| Ratios | |||||||
| ROE | 100.0% | -19.7% | - | - | - | - | - |
| ROA | 48.1% | -0.7% | -2.7% | -178.0% | -262.0% | -339.5% | - |
| Net Profit Margin | 10.6% | -0.9% | -13.1% | -8,085.5% | -6,805.1% | -15,299.2% | 3,201.8% |
| Debt to Equity | 1.08x | 28.74x | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
CuraScientific Corp. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | USD 3.90K | 6.36 | - |
| 2018 | USD 14.9K | 24 | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:500 on Apr 24, 2023.
Who owns CuraScientific Corp.
- Insiders 0.00%
- Institutions 0.00%
- Public & others 100.00%
- Shares outstanding 3.77B
- Free float 2.81B
CuraScientific Corp. company profile
- Company name
- CuraScientific Corp.
- Ticker
- CSTF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 2
- Fiscal year end
- December
- Address
- 51544 Cesar Chavez Street, Coachella, CA, United States, 92236
- Phone
- 909 435 1642
- Website
- curascientificcorp.com
About CuraScientific Corp.
CuraScientific Corp. engages in the manufacturing, distribution, and sale of cannabis products under the JW Brands and Chad Enterprises brand names. It offers cannabidiol, kava, and kratom. The company was formerly known as Boon Industries, Inc. and changed its name to CuraScientific Corp. in April 2023. CuraScientific Corp. was incorporated in 2020 and is based in Coachella, California.
CuraScientific Corp. management
3- Mr. Justin GonzalezChief Operating Officer · born 1981
- Mr. Johann LoewenChief Revenue Officer · born 1976
- Mr. Samuel L. BerryCEO, President, Secretary & Interim Chairman of the Board · born 1979